Global Meningococcal Vaccines Market was valued at 1,938 million in 2019 which is expected to reach USD 4,196 million by 2030 at CAGR 9.3%.
Meningitis is caused by various fungi, bacteria, and viruses. The bacterial form of meningitis is called as meningococcal meningitis which is caused by Neisseria meningitides (meningococcus) bacteria. Meningococcal meningitis disease is prevented by using meningococcal vaccines.
Increase n number of reportable cases of individuals suffering from meningococcal meningitis in the Sub-Saharan African region is the key driving factor which is expected to boost the global meningococcal vaccines market growth. For instance, in 2018, according to World Economic Forum’s report around 37.4 million tourist arrivals were recorded in Sub-Saharan Africa. Furthermore, increase in government awareness programs as well as rise in government interventions in refining healthcare infrastructure will have the positive impact on growth of global meningococcal vaccines market. Moreover, increase in research & development activities for meningococcal vaccine which is expected to boost the global meningococcal vaccines market growth.
However, stringent government rules and regulations for approval is the major restraining factor which is expected to hamper the global meningococcal vaccines market growth. Also, product recall of several products due to contamination will affect the global meningococcal vaccines market growth.
Global Meningococcal Vaccines Market is segmented into vaccine serotype such as MenAC, MenA, MenC, MenB & Manic, and MenACWY, by vaccine type such as Subcapsular, Polysaccharide, and Conjugate. Further, Global Meningococcal Vaccines Market is segmented into end user such as Adult, Pediatric, and Travelers.
Also, Global Meningococcal Vaccines Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Serum Institute of India Pvt. Ltd, Emergent BioSolutions, Inc, Sanofi, Merck & Co., Inc, GlaxoSmithKline, plc, and Pfizer Inc.
By Vaccine Serotype
MenAC MenA MenC MenB & Manic MenACWY
By Vaccine Type
Subcapsular Polysaccharide Conjugate
By End User
Adult Pediatric Travelers
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Meningococcal Vaccines Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Meningococcal Vaccines Market, By Vaccine Serotype
5.1 Y-o-Y Growth Comparison, By Vaccine Serotype
5.2 Global Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
5.3 Global Meningococcal Vaccines Market Size and Forecast, By Vaccine Serotype
5.3.1 MenAc
5.3.2MenA
5.3.3 MenC
5.3.4 MenB & Manic
5.3.5MenACWY
6 Global Meningococcal Vaccines Market, By Vaccine Type
6.1 Y-o-Y Growth Comparison, By Vaccine Type
6.2 Global Meningococcal Vaccines Market Share Analysis, By Vaccine Type
6.3 Global Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
6.3.1 Subcapsular
6.3.2 Polysaccharide
6.3.3 Conjugate
7 Global Meningococcal Vaccines Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Meningococcal Vaccines Market Share Analysis, By End User
7.3 Global Meningococcal Vaccines Market Size and Forecast, By End User
7.3.1 Adult
7.3.2 Paediatric
7.3.3 Travelers
8Global Meningococcal Vaccines Market, By Region
8.1 Global Meningococcal Vaccines Market Share Analysis, By Region
8.2 Global Meningococcal Vaccines Market Share Analysis, By Region
8.3 Global Meningococcal Vaccines Market Size and Forecast, By Region
9 North America Meningococcal Vaccines Market Analysis and Forecast (2017 – 2030)
9.1 Introduction
9.2 North America Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
9.3 North America Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
9.4 North America Meningococcal Vaccines Market Size and Forecast, By End User
9.5 North America Meningococcal Vaccines Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10Europe Meningococcal Vaccines Market Analysis and Forecast (2017 – 2030)
10.1 Introduction
10.2 Europe Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
10.3 Europe Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
10.4 Europe Meningococcal Vaccines Market Size and Forecast, By End User
10.5 Europe Meningococcal Vaccines Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Meningococcal Vaccines Market Analysis and Forecast (2017 – 2030)
11.1 Introduction
11.2 Asia Pacific Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
11.3 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
11.4 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By End User
11.5 Asia Pacific Meningococcal Vaccines Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Meningococcal Vaccines Market Analysis and Forecast (2017 – 2030)
12.1 Introduction
12.2 Latin America Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
12.3 Latin America Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
12.4 Latin America Meningococcal Vaccines Market Size and Forecast, By End User
12.5 Latin America Meningococcal Vaccines Market Size and Forecast, Country
13Middle East Meningococcal Vaccines Market Analysis and Forecast (2017 – 2030)
13.1 Introduction
13.2 Middle East Meningococcal Vaccines Market Share Analysis, By Vaccine Serotype
13.3 Middle East Meningococcal Vaccines Market Size and Forecast, By Vaccine Type
13.4 Middle East Meningococcal Vaccines Market Size and Forecast, By End User
13.5 Middle East Meningococcal Vaccines Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Serum Institute of India Pvt. Ltd
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Emergent BioSolutions, Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Sanofi
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Merck & Co., Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 GlaxoSmithKline, plc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Pfizer Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
